Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-8,668
Closed -$523K – 1570
2025
Q1
$523K Sell
8,668
-8,877
-51% -$572K ﹤0.01% 1052
2024
Q4
$1.2M Sell
17,545
-1,525
-8% -$106K ﹤0.01% 838
2024
Q3
$1.37M Buy
19,070
+2,956
+18% +$209K ﹤0.01% 800
2024
Q2
$1.12M Buy
16,114
+6,205
+63% +$453K ﹤0.01% 830
2024
Q1
$793K Buy
9,909
+193
+2% +$17.2K ﹤0.01% 953
2023
Q4
$1.06M Sell
9,716
-152
-2% -$15.7K ﹤0.01% 843
2023
Q3
$995K Sell
9,868
-383
-4% -$44K ﹤0.01% 842
2023
Q2
$1.39M Sell
10,251
-3,270
-24% -$399K 0.01% 758
2023
Q1
$1.4M Buy
13,521
+264
+2% +$25.5K 0.01% 745
2022
Q4
$1.18M Sell
13,257
-66
-0.5% -$5.48K ﹤0.01% 794
2022
Q3
$1.07M Buy
13,323
+82
+0.6% +$7.74K ﹤0.01% 801
2022
Q2
$1.27M Buy
13,241
+2,789
+27% +$335K 0.01% 694
2022
Q1
$1.55M Buy
10,452
+295
+3% +$41.2K 0.01% 633
2021
Q4
$1.44M Buy
10,157
+447
+5% +$63.3K 0.01% 662
2021
Q3
$1.27M Buy
9,710
+1,875
+24% +$245K 0.01% 691
2021
Q2
$1.08M Sell
7,835
-484
-6% -$66.3K ﹤0.01% 738
2021
Q1
$1.09M Buy
8,319
+636
+8% +$76.5K ﹤0.01% 716
2020
Q4
$861K Buy
7,683
+4,118
+116% +$390K ﹤0.01% 825
2020
Q3
$280K Buy
3,565
+121
+4% +$9.87K ﹤0.01% 1272
2020
Q2
$248K Buy
+3,444
New +$240K ﹤0.01% 1281

Other funds holding CNMD

M&T Bank's CNMD Position: Q2 2025 in Review

M&T Bank sold out of CONMED (CNMD) in Q2 2025, closing a stake of 8,668 shares — an estimated $523K sold.

M&T Bank first reported a position in CNMD in Q2 2020 and held it in 20 quarters. The position peaked at $1.55M in Q1 2022. 277 funds tracked by Wall St. Rank hold CNMD as of Q2 2025.

  • M&T Bank reported no remaining CONMED position as of Q2 2025 after selling out during the quarter.
  • M&T Bank sold 8,668 CONMED shares in Q2 2025, an estimated $523K.
  • M&T Bank first reported a position in CONMED in Q2 2020 and held it in 20 quarters.
  • M&T Bank's CONMED position peaked at $1.55M in Q1 2022.
  • 277 funds tracked by Wall St. Rank held CONMED as of Q2 2025.

Based on M&T Bank's 13F filing for Q2 2025, filed 13 Aug 2025.